JIE MENG | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr. JIE MENG | Neuroscience | Best Researcher Award 🏆

Assistant Professor at Sichuan University, China.

Dr. Jie Meng is an Assistant Professor at Sichuan University, China. With expertise in [specific field, e.g., molecular biology, environmental science, engineering], Dr. Meng has contributed significantly to both research and teaching. His work focuses onDr. Meng has published [number] papers in reputed journals and actively participates in academic conferences. He is committed to advancing knowledge in his field while fostering a collaborative learning environment for students at Sichuan University.

Profile

ORCID

Scopus

Education 🎓:

Jie Meng holds a Ph.D. in Neuroscience from Kyushu University, Japan, completed in 2019. This advanced education provided a solid foundation in understanding the intricate mechanisms underlying neurodegenerative diseases.

Work Experience 💼:

Jie Meng is currently an Intermediate Researcher at Sichuan University West China Hospital in Chengdu, China, a position held since 2019. In this role, Jie Meng conducts cutting-edge research into neurodegenerative diseases, focusing particularly on Alzheimer’s disease and Parkinson’s disease.

Awards and Honors

Jie Meng’s exceptional contributions to the field of neuroscience have been recognized with several awards, including the Qinghai Province Science and Technology Award, where he received the Second Prize in Natural Science for his innovative work in neurodegeneration research.

Research Interests:

Jie Meng’s research primarily revolves around the mechanisms of neurodegenerative diseases, with a strong emphasis on microglia-mediated neuroinflammation in Alzheimer’s disease (AD). His work seeks to identify novel epigenetic biomarkers for early-onset Parkinson’s disease (PD) and explore therapeutic strategies aimed at mitigating chronic neuroinflammation.,Investigating the role of microglia in neuroinflammation and how it contributes to AD progression.,Exploring epigenetic biomarkers that can aid in the early detection of Parkinson’s disease.,Developing innovative therapeutic approaches to target chronic neuroinflammation in neurodegenerative disorders.

📚 Publication 

  • Testing cognitive normal for Alzheimer’s disease prediction
    Citations: 0
    Year: 2025
    Authors: Meng, J., Lei, P.
    Journal: Journal of Neurochemistry

 

  • Iron promotes both ferroptosis and necroptosis in the early stage of reperfusion in ischemic stroke
    Citations: 2
    Year: 2024
    Authors: Du, B., Deng, Z., Chen, K., Tuo, Q.-Z., Lei, P.
    Journal: Genes and Diseases

 

 

  • How brain ‘cleaners’ fail: Mechanisms and therapeutic value of microglial phagocytosis in Alzheimer’s disease
    Citations: 12
    Year: 2024
    Authors: Ni, J., Xie, Z., Quan, Z., Meng, J., Qing, H.
    Journal: GLIA

 

  • Thrombin induces ferroptosis in triple-negative breast cancer through the cPLA2α/ACSL4 signaling pathway
    Citations: 5
    Year: 2024
    Authors: Xu, S., Tuo, Q.-Z., Meng, J., Li, C.-L., Lei, P.
    Journal: Translational Oncology

 

 

  • Leucine-rich repeat kinase 2 (LRRK2) inhibition upregulates microtubule-associated protein 1B to ameliorate lysosomal dysfunction and parkinsonism
    Citations: 3
    Year: 2023
    Authors: Chen, K., Tang, F., Du, B., Lei, P., Wei, X.-W.
    Journal: MedComm

 

  • The Dual Nature of Microglia in Alzheimer’s Disease: A Microglia-Neuron Crosstalk Perspective
    Citations: 8
    Year: 2023
    Authors: Xie, Z., Meng, J., Wu, Z., Qing, H., Ni, J.
    Journal: Neuroscientist

 

  • Scopolamine causes delirium-like brain network dysfunction and reversible cognitive impairment without neuronal loss
    Citations: 8
    Year: 2023
    Authors: Wang, Q., Zhang, X., Guo, Y.-J., Yue, J.-R., Lei, P.
    Journal: Zoological Research

 

  • Microglial cathepsin E plays a role in neuroinflammation and amyloid β production in Alzheimer’s disease
    Citations: 14
    Year: 2022
    Authors: Xie, Z., Meng, J., Kong, W., Qing, H., Ni, J.
    Journal: Aging Cell

 

  • Differential Expression and Distinct Roles of Proteinase-Activated Receptor 2 in Microglia and Neurons in Neonatal Mouse Brain After Hypoxia-Ischemic Injury
    Citations: 6
    Year: 2022
    Authors: Liu, Y., Li, H., Hu, J., Qing, H., Ni, J.
    Journal: Molecular Neurobiology

 

  • Nucleus distribution of cathepsin B in senescent microglia promotes brain aging through degradation of sirtuins
    Citations: 28
    Year: 2020
    Authors: Meng, J., Liu, Y., Xie, Z., Lei, P., Ni, J.
    Journal: Neurobiology of Aging

 

Conclusion 

In conclusion, to fully assess Dr. Jie Meng’s suitability for the Best Researcher Award, one would need to gather detailed information on their research outputs, contributions to the field, collaborations, and overall recognition. If their work aligns with the criteria outlined above, Dr. Meng could very well be a strong contender for the award. Additionally, providing more details on their specific research achievements would allow for a more tailored evaluation and clearer recommendations for areas where they could continue to excel.

 

Harender Kumar | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr. Harender Kumar | Neuroscience | Best Researcher Award 🏆

Research Scholar at Panjab University Chandigarh, India.

Harender Kumar, a Research Scholar at Panjab University, Chandigarh, specializes in behavioral neuroscience. His work primarily focuses on investigating the relationship between diet, gut health, and stress resilience using zebrafish as a model organism. Kumar has published three notable journal articles in SCI/Scopus-indexed journals, with impactful contributions to neuroscience and chemistry. His research demonstrates a promising ability to bridge fundamental science with potential real-world applications.

Profile

Scopus

Education 🎓:

Harender Kumar is pursuing his Ph.D. at Panjab University, Chandigarh, focusing on behavioral neuroscience. His academic journey reflects his dedication to understanding the complex interplay between biological systems and mental health. Harender’s educational background has provided a strong foundation in neuroscience, biology, and chemistry, enabling him to engage in cutting-edge research. At Panjab University, he has honed his expertise in experimental design, data analysis, and interdisciplinary collaboration, contributing significantly to his academic and professional growth. Through his education, Harender has developed a keen interest in the gut-brain axis, stress mechanisms, and the therapeutic potential of dietary interventions, preparing him for a promising career in research and innovation.

Work Experience 💼:

Harender Kumar has significant experience in behavioral neuroscience research, with a focus on gut-brain interactions and stress resilience. As a Research Scholar at Panjab University, he has conducted innovative studies using zebrafish models, exploring how dietary components influence mental health. Harender has collaborated with experts in chemistry to address diverse scientific challenges, such as detecting chemical agents and understanding synaptic remodeling. His hands-on expertise includes experimental planning, animal model studies, and data interpretation, which have resulted in publications in SCI/Scopus-indexed journals. Harender’s multidisciplinary experience reflects his ability to navigate complex scientific questions and contribute meaningfully to neuroscience and beyond.

Awards and Honors

Though specific awards and honors are not mentioned in the profile, Harender Kumar’s accomplishments in publishing high-quality research in reputable journals demonstrate academic recognition. His work has contributed to advancing behavioral neuroscience and interdisciplinary science. Securing awards such as research grants, best paper accolades, or conference presentations would further highlight his achievements and scholarly impact.

Research Interests:

Harender Kumar’s research centers on behavioral neuroscience, with an emphasis on understanding the gut-brain axis and its role in stress resilience. Using zebrafish as a model organism, he investigates the link between dietary factors and mental well-being, providing insights into potential therapeutic strategies. His multidisciplinary work integrates neuroscience, physiology, and chemistry, addressing critical issues such as synaptic remodeling and the stress-resilient effects of dietary interventions. Harender’s innovative approach has contributed to a deeper understanding of mental health challenges and opened avenues for novel dietary strategies to enhance emotional resilience.

📚 Publications 

Stress-resilient Effect of Spirulina platensis on Zebrafish Chronic Unpredictable Stress Model

Authors: Kumar, H., Kaur, K., Kaur, R.

Journal: Physiology & Behavior

Year: 2024

Citations: 0

Role of Spirulina in Structural Remodeling of Synapse in Telencephalon of Chronic Unpredictable Stress Model of Zebrafish

Authors: Kumar, H., Garg, V., Kaur, K., Kaur, R.

Journal: Annals of Neurosciences

Year: 2023

Citations: 0

Synthesis of a Trinuclear Zinc(II) Cluster Composed of [4.4.3.01,5]Tridecane Cages: A Rapid Detection and Degradation Probe for the Chemical Warfare Agent Simulant Diethyl Cyanophosphonate in Protein-rich Food Products

Authors: Thakur, S., Rohilla, J., Kumar, K., Kumar, H., Singh, R., Kaur, V., Kamboj, R.

Journal: Analyst

Year: 2023

Citations: 4

Conclusion 

Harender Kumar exhibits strong potential as a researcher in behavioral neuroscience, with impactful publications and an innovative focus on the gut-brain axis. While his current portfolio demonstrates high-quality research and interdisciplinary collaboration, there is room to enhance his profile by securing funded projects, expanding his professional engagement, and increasing the impact of his work through broader dissemination and applications. Overall, Harender is a commendable candidate for the Best Researcher Award, particularly for early-career recognition.

 

 

Amir Hossein Zarifkar | Neuroscience | Best Researcher Award

Posted on by sciencefather

Assist. Prof. Dr. Amir Hossein Zarifkar | Neuroscience | Best Researcher Award 🏆

Faculty member at Larestan University of Medical Sciences, Iran.

Dr. Amir Hossein Zarifkar is a dedicated researcher in the field of neurophysiology, specializing in Alzheimer’s disease models, memory impairment, and the effects of transcranial electrical stimulation. He holds a Ph.D. in Physiology, and his expertise includes stereotaxic surgery, cognitive testing, and advanced biochemical and histological techniques. His research contributions are evidenced by peer-reviewed publications, prestigious awards, and active participation in scientific conferences. As a teacher, he has guided students across multiple disciplines in physiology, further demonstrating his commitment to academia.

Profile

Scopus

Google Scholar

Education 🎓:

Dr. Zarifkar’s academic journey began with a B.Sc. in Biology from Shiraz University, Iran (2010), where he laid the foundation for his passion in life sciences. He pursued his M.Sc. in Physiology at Ahvaz University of Medical Sciences (2014), conducting a thesis on the protective effects of agmatine in memory impairment models. Building upon this expertise, Dr. Zarifkar earned a Ph.D. in Physiology from Shiraz University of Medical Sciences (2019). His doctoral research, titled “Investigating the effect of transcranial electrical stimulation (tES) paradigms on beta-amyloid-induced memory impairment and hippocampal CA1 structural changes in male rats,” received critical acclaim for its innovative approach to addressing Alzheimer’s disease. Throughout his education, Dr. Zarifkar consistently ranked among the top of his cohort, achieving first rank in the national Ph.D. entrance exam and being honored as a top student at Shiraz University of Medical Sciences.

Work Experience 💼:

Dr. Zarifkar has over a decade of experience in teaching, research, and experimental neurophysiology. As an educator, he delivers comprehensive courses in nervous system, kidney, gastrointestinal, and endocrine physiology to students in medicine, dentistry, pharmacy, and nursing. His hands-on laboratory sessions emphasize practical applications of physiology, fostering a deeper understanding among students. On the research front, Dr. Zarifkar specializes in Alzheimer’s disease, memory impairment, and innovative therapeutic approaches, utilizing advanced methodologies such as transcranial electrical stimulation, immunohistochemistry, and stereotaxic surgery. His expertise extends to conducting behavioral and cognitive experiments in animal models. Dr. Zarifkar’s findings have been presented at national and international conferences, enhancing the global understanding of neurodegenerative diseases. As a member of Iran’s National Elites Foundation, he actively contributes to academic and research communities, solidifying his role as a leader in the field of neurophysiology.

Awards and Honors 🏆

Dr. Zarifkar has received multiple awards and recognitions for his academic excellence and contributions to neuroscience. Notably, he ranked first in the national Ph.D. entrance exam in Physiology, demonstrating his exceptional knowledge in the field. During his M.Sc. and Ph.D. studies, he was honored as a top student at Shiraz University of Medical Sciences. His groundbreaking research on Alzheimer’s disease earned him accolades at national and international scientific conferences. Dr. Zarifkar is also a proud member of Iran’s National Elites Foundation, a prestigious acknowledgment of his academic and research achievements. His dedication to teaching and mentoring has further earned him the respect and admiration of his peers and students alike. These honors reflect Dr. Zarifkar’s unwavering commitment to advancing the field of physiology and contributing to the understanding and treatment of neurodegenerative disorders.

Research Interests:

Dr. Zarifkar’s research centers on understanding the mechanisms underlying neurodegenerative diseases, particularly Alzheimer’s disease, and developing innovative therapeutic strategies. His Ph.D. work investigated the effects of transcranial electrical stimulation (tES) on memory impairment and structural changes in the hippocampus, providing insights into non-invasive treatments for Alzheimer’s. Dr. Zarifkar’s expertise extends to studying the impact of neuroprotective agents like agmatine on cognitive functions and neural plasticity. He employs advanced methodologies, including behavioral and cognitive assessments in animal models, immunohistochemistry, Western blot analysis, and stereotaxic surgery, to unravel the complexities of memory impairment. His findings contribute to a better understanding of the pathophysiology of neurodegenerative disorders and pave the way for potential clinical applications. By bridging experimental neuroscience with translational research, Dr. Zarifkar aims to develop effective interventions for enhancing cognitive health and mitigating the effects of aging-related neurological conditions.

📚 Publications 

Agmatine protects against intracerebroventricular streptozotocin-induced water maze memory deficit, hippocampal apoptosis, and Akt/GSK3β signaling disruption

Authors: M. Moosavi, A.H. Zarifkar, Y. Farbood, M. Dianat, A. Sarkaki, R. Ghasemi

Citations: 46

Year: 2014

Treatment with edaravone improves the structure and functional changes in the hippocampus after chronic cerebral hypoperfusion in rats

Authors: G.H. Meftahi, M. Bayat, A.H. Zarifkar, S. Akbari, A.B. Haghighi, M. Naseh

Citations: 18

Year: 2021

Ameliorative effects of different transcranial electrical stimulation paradigms on the novel object recognition task in a rat model of Alzheimer disease

Authors: A.H. Zarifkar, A. Zarifkar, M. Nami, A. Rafati, H. Aligholi, F. Vafaee

Citations: 12

Year: 2019

Effect of recombinant insulin-like growth factor-2 injected into the hippocampus on memory impairment following hippocampal intracerebral hemorrhage in rats

Authors: F. Vafaee, A. Zarifkar, M. Emamghoreishi, M.R. Namavar, M. Shahpari

Citations: 10

Year: 2018

Interactive Effects of Swimming High-Intensity Interval Training and Resveratrol Supplementation Improve Mitochondrial Protein Levels in the Hippocampus of Aged Rats

Authors: M. Amirazodi, F. Daryanoosh, A. Mehrabi, A. Gaeini, M. Koushkie Jahromi

Citations: 6

Year: 2022

The Comparison of the Effects of Different Transcranial Electrical Stimulation (tES) Paradigms on Beta-Amyloid (Aβ 25–35)-Induced Memory Impairment upon Morris Water Maze Task

Authors: A.H. Zarifkar, A. Zarifkar, M. Nami, A. Rafati, H. Aligholi

Citations: 5

Year: 2018

Different paradigms of transcranial electrical stimulation improve motor function impairment and striatum tissue injuries in the collagenase-induced intracerebral hemorrhage model

Authors: A.R. Heidarzadegan, A. Zarifkar, N. Sotoudeh, M.R. Namavar, A.H. Zarifkar

Citations: 4

Year: 2022

The protective effect of agmatine against intracerebroventricular streptozotocin-induced memory impairment in male rats

Authors: Y. Farbood, A.H. Zarifkar, M. Dianat, A. Sarkaki, M. Moosavi

Citations: 1

Year: 2014

Resistance Training and Resveratrol Supplementation Improve Cancer Cachexia and Tumor Volume in Muscle Tissue of Male Mice Bearing Colon Cancer CT26 Cell Tumors

Authors: M. Samadi, F. Daryanoosh, Z. Mojtahedi, A. Samsamy Pour, H. Nobari

Citations: Not yet cited

Year: 2024

Alterations in FoxO3a, NF-κB, and MuRF1 Expression in the Soleus Muscle of Male Rats Following High-Intensity Interval Training and Detraining

Authors: S. Sheibani, F. Daryanoosh, A.H. Zarifkar

Citations: Not yet cited

Year: 2024

Different paradigms of transcranial electrical stimulation induce structural changes in the CA1 region of the hippocampus in a rat model of Alzheimer’s disease

Authors: A.H. Zarifkar, A. Zarifkar, S. Safaei

Citations: Not yet cited

Year: 2024

P62: Agmatine Protects Against Intracerebroventricular Streptozotocin-Induced Water Maze Memory Deficit, Hippocampal Apoptosis and Akt/GSK3β Signaling Disruption

Authors: M. Moosavi, A.H. Zarifkar, Y. Farbood, M. Dianat, A. Sarkaki, R. Ghasemi

Citations: Not listed

Year: 2018

Conclusion 

Dr. Amir Hossein Zarifkar demonstrates an exceptional commitment to advancing neurophysiology research and teaching. His strengths, including rigorous experimental skills, teaching proficiency, and recognized achievements, position him as a strong candidate for a Best Researcher Award. Addressing areas like international visibility, grant acquisition, and translational focus could further strengthen his profile. Overall, his impactful contributions to Alzheimer’s research and academic excellence make him a deserving nominee.

 

 

Ioannis Charalampopoulos | Neuroscience | Best Researcher Award

Posted on by sciencefather

Prof. Ioannis Charalampopoulos
| Neuroscience | Best Researcher Award 🏆

Professor of Pharmacology at Medical School, University of Crete,Greece🎓

Dr. Ioannis Charalampopoulos is a distinguished Professor of Pharmacology at the University of Crete’s Medical School and a Group Leader at the Institute of Molecular Biology and Biotechnology (IMBB), Foundation of Research and Technology, Hellas (FORTH). With a focus on neuropharmacology and molecular biology, his research has contributed significantly to the study of neurodegenerative diseases, brain development, and regeneration. He has an extensive academic and research career spanning over two decades, with notable achievements in the development of novel therapeutic strategies for Alzheimer’s and spinal cord injury.

 

Professional Profile 

Education 🎓:

  • 2021-present: Director of the Graduate Program in Neurosciences, Medical School, University of Crete
  • 2010-2023: Lecturer, Assistant and Associate Professor of Pharmacology, Medical School, University of Crete
  • 2007-2010: Researcher, Medical School, University of Crete
  • 2005-2007: Post-doctoral Fellow, Molecular Neurobiology Lab, Karolinska Institutet, Sweden
  • 2001-2005: PhD in Pharmacology, Medical School, University of Crete
  • 1998-2000: Master of Science in Neurosciences, Medical School, University of Crete
  • 1990-1996: BSc, Department of Biology, University of Patras

Work Experience 💼:

  • 2023-present: Professor of Pharmacology, Medical School, University of Crete
  • 2018-present: Researcher/Group Leader, Institute of Molecular Biology and Biotechnology (IMBB), FORTH
  • 2021-present: Director, Graduate Program in Neurosciences, Medical School, University of Crete
  • 2010-2023: Lecturer, Assistant and Associate Professor of Pharmacology, University of Crete
  • 2007-2010: Researcher, Medical School, University of Crete
  • 2005-2007: Post-doctoral Fellow, Molecular Neurobiology Lab, Karolinska Institutet, Sweden

Skills 🔍

Dr. Charalampopoulos is highly skilled in neuropharmacology, molecular biology techniques, and neurodegenerative disease research. His expertise includes:

  • Neurotrophin receptor structure-function analysis
  • Development of therapeutic ligands for brain regeneration
  • Neurogenesis and neuroprotection strategies
  • Animal models of Alzheimer’s disease and spinal cord injury
  • Human iPSC-derived neural platforms for disease modeling
  • Collaborative research in neuroscience and pharmacology

Awards and Honors 🏆

Dr. Charalampopoulos has received multiple recognitions throughout his career, including prestigious grants for his innovative work in neuroscience and neurodegenerative disease treatment:

  • HORIZON-EIC-2022 European Commission Grant: Coordinating a project on soft-robot-assisted therapeutic delivery for neurological disorders (budget: 2.9 million euros).
  • National Flagship Project: Funding for the elucidation of the genetic basis of Alzheimer’s and Parkinson’s diseases (budget: 610,000 euros).
  • Numerous research accolades, with over 80 publications in peer-reviewed journals (h-index: 35, citations >3000).

🤝 Memberships:

Dr. Charalampopoulos is a member of several prestigious scientific organizations, including:

  • International Society for Neuroscience
  • European Society of Neurochemistry
  • Society for Neuroscience (SfN)
  • Greek Society for Pharmacology

Teaching Experience 👩‍🏫:

Dr. Charalampopoulos has been actively involved in educating future generations of neuroscientists, particularly through his role as the Director of the Graduate Program in Neurosciences at the University of Crete. His teaching experience includes:

  • Undergraduate and postgraduate courses in pharmacology, neuropharmacology, and molecular biology.
  • Mentoring and supervising PhD students and postdoctoral researchers in pharmacology and neuroscience.
  • Developing innovative teaching methods, including the use of human stem cell models in neuroscience research.

Research Focus 🔬:

Dr. Charalampopoulos’ research interests revolve around the molecular mechanisms by which growth factors and their receptors regulate the regenerative capacity of the nervous system. Key areas include:

  • Neurotrophins: Their role in brain development, neurogenesis, neuronal survival, and repair during aging.
  • Neurodegenerative Diseases: Investigating novel therapeutic strategies for Alzheimer’s disease, Parkinson’s disease, and spinal cord injury.
  • Ligand Development: Creating novel ligands targeting neurotrophin receptors to enhance regenerative and neuroprotective effects.
  • Stem Cell Models: Using human induced pluripotent stem cell-derived platforms to test therapeutics for neurodegenerative diseases.
    His ultimate goal is to decipher the signaling mechanisms underlying neurodegeneration and regeneration, leading to the development of novel drugs for brain repair.
Conclusion 

Dr. Ioannis Charalampopoulos is undoubtedly a top contender for the Best Researcher Award. His exceptional contributions to neuroscience, his innovative approaches in neuropharmacology, and his ability to secure substantial research funding demonstrate that he is not only an accomplished researcher but also a transformative figure in the field of neurodegenerative diseases. His strengths lie in the originality of his work, leadership in research initiatives, and mentorship in education. With slight improvements in public outreach, collaborative networks, and clinical translation, he can further elevate his already remarkable career. Therefore, Dr. Charalampopoulos is a highly deserving nominee for the Best Researcher Award, given his outstanding scientific contributions, leadership, and lasting impact on the field of neuroscience.

📚 Publilcation

  • “Stimulating myelin restoration with BDNF: a promising therapeutic approach for Alzheimer’s disease”
    • Year: 2024
    • Journal: Frontiers in Cellular Neuroscience
    • Type: Review
    • DOI: 10.3389/fncel.2024.1422130
  • “Editorial: Steroid receptors in neuron and glia”
    • Year: 2024
    • Journal: Frontiers in Endocrinology
    • Type: Editorial
    • DOI: 10.3389/fendo.2024.1472908
  • “Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer’s disease”
    • Year: 2024
    • Journal: Stem Cell Research & Therapy
    • Type: Journal Article
    • DOI: 10.1186/s13287-024-03818-w
  • “Cover Image, Volume 72, Issue 4”
    • Year: 2024
    • Journal: Glia
    • Type: Journal Article
    • DOI: 10.1002/glia.24399
  • “Dynamics of myelin deficits in the 5xFAD mouse model for Alzheimer’s disease and the protective role of BDNF”
    • Year: 2024
    • Journal: Glia
    • Type: Journal Article
    • DOI: 10.1002/glia.24505
  • “Multimodal beneficial effects of BNN27, a Nerve Growth Factor synthetic mimetic, in the 5xFAD mouse model of Alzheimer’s Disease”
    • Year: 2024
    • Type: Preprint
    • DOI: 10.21203/rs.3.rs-3886007/v1
  • “Development of Pleiotropic TrkB and 5-HT<sub>4</sub> Receptor Ligands as Neuroprotective Agents”
    • Year: 2024
    • Journal: Molecules
    • Type: Journal Article
    • DOI: 10.3390/molecules29020515
  • “Butanolides and Butenolides from a Marine-Derived Streptomyces sp. Exert Neuroprotective Activity through Activation of the TrkB Neurotrophin Receptor”
    • Year: 2023
    • Journal: Marine Drugs
    • Type: Journal Article
    • DOI: 10.3390/md21090465
  • “Neurotrophin Analog ENT-A044 Activates the p75 Neurotrophin Receptor, Regulating Neuronal Survival in a Cell Context-Dependent Manner”
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
    • Type: Journal Article
    • DOI: 10.3390/ijms241411683
  • “Neurotrophin Analog ENT-A044 Activates the p75 Neurotrophin Receptor Promoting Cell Death in Mouse and Human Neuronal Cells”
    • Year: 2023
    • Type: Preprint
    • DOI: 10.20944/preprints202306.1633.v1

Prof Dr Katsunori Nonogaki | Neuroscience | Best Researcher Award

Posted on by sciencefather

Prof Dr Katsunori Nonogaki | Neuroscience | Best Researcher Award 🏆

Division of Diabetes and Nutrition at RARiS, Tohoku University, Japan
🎓

Dr. Katsunori Nonogaki is a distinguished professor and clinical specialist in diabetes and internal medicine, holding extensive expertise in lifestyle medicine and diabetes research. He obtained his MD in Japan in 1987, followed by a PhD from Nagoya University Graduate School of Medicine in 1993. His postdoctoral training included positions at UCSF and The Scripps Research Institute, where he focused on metabolism and neuropharmacology. Dr. Nonogaki has held key academic roles at prestigious institutions, including the University of Tokyo and Tohoku University, where he has been a professor since 2008.

Professional Profile 

📚 Work Experience & Teaching

Dr. Nonogaki has a long-standing academic career, beginning as a lecturer at the University of Tokyo before joining Tohoku University in various professorial roles. His teaching experience spans undergraduate to postgraduate levels, where he mentors future leaders in diabetes research and metabolic health.

🎖️ Skills, Awards, and Honors

Dr. Nonogaki is highly skilled in molecular nutrition, metabolic diseases, and translational research. He has served as the Chief of the Laboratory of Molecular Nutrition and is recognized for his contributions to diabetes research, earning several awards in this domain. He has also made impactful contributions to scientific literature, serving on the editorial boards of key journals such as Frontiers in Endocrinology and Diabetes Research and Clinical Practice.

🌐 Memberships & Professional Involvement

His professional involvement extends to numerous editorial roles, including Topic Editor and Associate Editor in leading journals. Dr. Nonogaki is a highly regarded member of the international diabetes research community, where he actively contributes to advancements in metabolic health and diabetes management.

Research Focus

Xiaofeng’s research is centered on entrepreneurial behavior, project selection, and risk assessment. He has proposed a three-stage theory for project selection and developed a dynamic measurement model for entrepreneurial risks. His work has practical implications, particularly in the evaluation of risks in family farms and entrepreneurship education. His 65 published journal articles and various patents further underscore his contributions to the field.

 

Publications : 

“The GLP-1 Receptor Agonist Liraglutide Decreases Primary Bile Acids and Serotonin in the Colon Independently of Feeding in Mice”
Year: 2024
Journal: International Journal of Molecular Sciences

Dr Alexandros Kanellopoulos | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr Alexandros Kanellopoulos Neuroscience | Best ResearcherAward  🏆

Principal Scientist of Cognitive Health at DSM-Firmenich, RD Innovation
Switzerland🎓

Alexandros Kanellopoulos is a seasoned Innovation Leader, Principal Scientist, and Clinical Director with over 20 years of expertise in Neuroscience, Metabolism, Early Life Nutrition (ELN), and Medical Nutrition. He has successfully led multidisciplinary teams, pioneered product innovations, and authored more than 20 high-impact publications. With 7 patents to his name, Alexandros excels in transforming scientific research into tangible solutions that meet market needs.

Professional Profile 

Education

Alexandros Kanellopoulos holds a Ph.D. in Neuroscience from Kapodistrian University, Greece (2008-2013), where his research focused on neurodevelopmental disorders. Prior to this, he completed his M.Sc. in Molecular Medicine (Neuroscience) at the same university (2005-2007), gaining advanced expertise in neuroscience and molecular biology. His academic foundation was established with a B.Sc. in Molecular Biology and Genetics from Dimocritus University of Thrace, Greece (2000-2005), where he developed a strong background in genetics and molecular biology.

Work Experience

In his current role as Global Principal Scientist & Clinical Director at DSM-Firmenich (2023-Present), Alexandros oversees scientific activities, driving innovation in dietary supplements and medical nutrition. Prior to this, he worked as an R&D Innovation Scientist and Project Manager at Nestle SA (2022-2023), leading the development of brain health products for Early Life Nutrition. In 2023, he also held the position of Medical, Scientific & Regulatory Affairs Manager at Nestle Nutrition, focusing on market communication and regulatory compliance. Alexandros previously served as Group Leader, Early Life Brain Metabolism at the University of Lausanne (2020-2022) and as Senior Scientist in Early Life Neuroscience (2016-2020), where he pioneered research in neurodevelopmental disorders.

Skills 

Alexandros is highly skilled in Innovation & Product Development, leading projects from concept to market. He is an expert in Clinical Research & Protocol Design, managing complex preclinical and clinical trials. His ability to lead multidisciplinary teams and drive Cross-functional Collaboration is complemented by his talent for Stakeholder Engagement & Market Alignment, ensuring alignment between research innovations and market needs. His Strategic Thinking, Problem-solving, and Emotional Intelligence are key to his success in high-impact research and business projects.

Awards & Honors

Throughout his career, Alexandros has earned more than 15 research awards, securing CHF 2.5 million in research funding. He has been awarded 7 patents as an inventor, reflecting his contributions to innovation in neuroscience and nutrition. In addition, he has delivered over 40 invited presentations at international conferences, establishing himself as a respected thought leader in his field.

 Membership 

Alexandros contributes to the scientific community as a Reviewer for leading neuroscience journals and serves as an Editor in scientific publications, ensuring the dissemination of high-quality research.

Teaching Experience

Alexandros is also an experienced educator, having delivered lectures in Neuroscience and Medical Sciences at the University of Lausanne and Kapodistrian University, Athens. In his academic roles, he has mentored over 20 junior scientists, fostering the next generation of researchers and innovators.

Research Focus

Alexandros’ research centers on Early Life Nutrition and its role in brain development. He is particularly focused on Neurodevelopmental Disorders such as Autism and Fragile X Syndrome. His work on Brain Energy Metabolism and Mitochondrial Function provides insights into neurotransmission and social behavior. Alexandros has also designed Preclinical and Clinical Research aimed at developing nutritional solutions to address these complex medical challenges.

Publications : 

  • Activation of the 5-HT1A Receptor by Eltoprazine Restores Mitochondrial and Motor Deficits in a Drosophila Model of Fragile X Syndrome
    🧠 International Journal of Molecular Sciences – 2024
    DOI: 10.3390/ijms25168787
  • Aralar Sequesters GABA into Hyperactive Mitochondria, Causing Social Behavior Deficits
    🧬 Cell – 2020
    DOI: 10.1016/j.cell.2020.02.044
  • Conserved Tao Kinase Activity Regulates Dendritic Arborization, Cytoskeletal Dynamics, and Sensory Function in Drosophila
    🔬 The Journal of Neuroscience – 2020
    DOI: 10.1523/jneurosci.1846-19.2020
  • Domain-Specific Cognitive Impairments in Humans and Flies With Reduced CYFIP1 Dosage
    🧩 Biological Psychiatry – 2019
    DOI: 10.1016/j.biopsych.2019.04.008
  • SynGO: An Evidence-Based, Expert-Curated Knowledge Base for the Synapse
    🧠 Neuron – 2019
    DOI: 10.1016/j.neuron.2019.05.002
  • Mitochondrial Dysfunction in Autism Spectrum Disorder: Clinical Features and Perspectives
    🧠 Current Opinion in Neurobiology – 2017
    DOI: 10.1016/j.conb.2017.05.018
  • Autism Spectrum Disorders: Translating Human Deficits into Mouse Behavior
    🐁 Neurobiology of Learning and Memory – 2015
    DOI: 10.1016/j.nlm.2015.07.013
  • Learning and Behavioral Deficits Associated with the Absence of the Fragile X Mental Retardation Protein: What a Fly and Mouse Model Can Teach Us
    🧠 Learning & Memory (Cold Spring Harbor, N.Y.) – 2014
    DOI: 10.1101/lm.035956.114
  • Learning and Memory Deficits Resulting from Reduction of the Fragile X Mental Retardation Protein: A Metabotropic Glutamate Receptor-Mediated Inhibition of cAMP Signaling in Drosophila
    🧠 The Journal of Neuroscience – 2012
    DOI: 10.1523/JNEUROSCI.1347-12.2012
  • Selective Serotonin Reuptake Inhibitors for the Treatment of Hypersensitive Esophagus: A Randomized, Double-blind, Placebo-controlled Study
    💊 The American Journal of Gastroenterology – 2011
    DOI: 10.1038/ajg.2011.179

Dr Andreu Massot Tarrús | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr Andreu Massot Tarrús | Neuroscience | Best Researcher Award 🏆

Neurologist at Hospital Universitari Mútua Terrassa, Spain🎓

Andreu Massot Tarrús, MD, PhD, is a highly accomplished neurologist and epileptologist with over 20 years of experience. He earned his Medical Doctorate from the Universitat Autònoma de Barcelona in 2003 and later completed a PhD Cum Laude in Medicine, focusing on intracranial atherostenosis. He has held senior neurology positions at prestigious hospitals in Spain, including Hospital Universitari Vall d’Hebron, Jiménez Díaz Foundation, and Hospital Universitari Mútua Terrassa, where he currently serves. Dr. Massot Tarrús has specialized expertise in epilepsy, EEG, and cerebrovascular diseases and has completed advanced fellowships in Canada and the UK.

Professional Profile 

Education

Andreu Massot Tarrús earned his Medical Doctorate in August 2003 from the Universitat Autònoma de Barcelona. He went on to complete his Neurology specialization in May 2009 at the Hospital Universitari Vall d’Hebron, Barcelona. In June 2013, he was awarded a PhD Cum Laude in Medicine by the same university for his thesis on intracranial atherostenosis, supervised by Dr. Montaner Villalonga and Dr. Álvarez-Sabín. His commitment to epilepsy research led him to a Clinical and Research Fellowship in Epilepsy and EEG at Western University, Ontario, in 2014, followed by a Master in Epilepsy from the Universidad de Murcia in 2018, where he received an excellent qualification.

 Work Experience

Dr. Massot Tarrús’s medical career has spanned several prestigious institutions. Starting as a clinical observer in London (2008), he then became a Senior Neurologist in Barcelona and Madrid, working in the Neurovascular Unit at Vall d’Hebron (2009-2010) and the Epilepsy Unit at the Jiménez Díaz Foundation (2010-2011). Between 2011 and 2021, he took on various senior roles, including at Hospital del Mar and Hospital Universitario Gregorio Marañón, Madrid. Since September 2021, he has been a Senior Neurologist and Epileptologist at Hospital Universitari Mútua Terrassa, where he continues to excel in treating neurological disorders, particularly epilepsy.

 Skills 

Dr. Massot Tarrús is highly skilled in Electroencephalography (EEG) and Video-EEG monitoring. He has extensive experience in intraoperative electrocorticography, cortical stimulation mapping, and the Wada test. His expertise in cerebrovascular diseases and ultrasonography diagnostics has made him a leading lecturer at several top hospitals, including Vall d’Hebron, Hospital del Mar, and Hospital Gregorio Marañón.

Awards & Honors

He holds certifications in Electroencephalography from both the Canadian Society of Clinical Neurophysiology (2015) and the Spanish Society of Neurology (2016). He was also awarded a Cum Laude distinction for his doctoral work and has participated in advanced training like the NIH Stroke Scale Training by the National Stroke Association.

 Membership 

Dr. Massot Tarrús is an active member of the Spanish Society of Neurology and has contributed significantly to clinical neurophysiology through his memberships in various international medical bodies.

 Teaching Experience

Dr. Massot Tarrús has shared his knowledge extensively, offering lectures on epilepsy, neurovascular diseases, and ultrasonography techniques. He has taught at institutions like Jiménez Díaz Foundation, Hospital del Mar, and Western University, where his work in EEG and cerebrovascular illness has helped shape the careers of future neurologists.

 Research Focus

His research primarily focuses on epilepsy and ischemic cerebrovascular diseases. His PhD thesis, which examined markers of recurrence in intracranial atherostenosis, highlights his dedication to improving diagnostics and treatment outcomes in neurology. He continues to contribute to research on epilepsy and cerebrovascular conditions, aiming to reduce the recurrence of ischemic events in patients.

 

📖Publications : 

  • 📄 “Real-world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program”
    Author: Massot-Tarrús, A.
    Journal: Epilepsia Open
    Year: 2023
    Volume: 8(3), pp. 918–929
  • 📊 “Risk factors for comorbid epilepsy in patients with psychogenic non-epileptic seizures. Dataset of a large cohort study”
    Author: Massot-Tarrús, A.
    Journal: Data in Brief
    Year: 2022
    Volume: 45, 108568
  • 🧠 “Roles of fMRI and Wada tests in the presurgical evaluation of language functions in temporal lobe epilepsy”
    Author: Massot-Tarrús, A.
    Journal: Frontiers in Neurology
    Year: 2022
    Volume: 13, 884730
  • 💊 “Perampanel as adjuvant treatment in epileptic encephalopathies: A multicenter study in routine clinical practice”
    Co-author: Massot-Tarrús, A.
    Journal: Epilepsy and Behavior
    Year: 2022
    Volume: 134, 108836
  • 📈 “Factors associated with comorbid epilepsy in patients with psychogenic nonepileptic seizures: A large cohort study”
    Author: Massot-Tarrús, A.
    Journal: Epilepsy and Behavior
    Year: 2022
    Volume: 134, 108780
  • 🧩 “Cortical myoclonus associated with coeliac disease showing a characteristic EEG pattern: A case report”
    Author: Massot-Tarrús, A.
    Journal: Seizure
    Year: 2022
    Volume: 95, pp. 81–83
  • 🚑 “Response to anakinra in new-onset refractory status epilepticus: A clinical case”
    Author: Massot-Tarrús, A.
    Journal: Seizure
    Year: 2022
    Volume: 94, pp. 92–94
  • 🦠 “Neurological complications of COVID-19 in hospitalized patients: The registry of a neurology department in the first wave of the pandemic”
    Co-author: Massot-Tarrús, A.
    Journal: European Journal of Neurology
    Year: 2021
    Volume: 28(10), pp. 3339–3347
  • 📉 “Predicting outcome of patients with psychogenic nonepileptic seizures after diagnosis in an epilepsy monitoring unit”
    Author: Massot-Tarrús, A.
    Journal: Epilepsy and Behavior
    Year: 2021
    Volume: 120, 108004
  • 🧬 “E200K familial Creutzfeldt-Jakob disease. MRI, EEG, PET and neuropathological correlation in a family”
    Co-author: Massot-Tarrús, A.
    Journal: Neurologia
    Year: 2021
    Volume: 36(5), pp. 399–401

 

Dr Roberta Gasparro | Neuroscience | Best Paper Award

Posted on by sciencefather

Dr Roberta Gasparro | Neuroscience | Best Paper Award 🏆

Research Fellow at University of Naples Federico II , Italy🎓

Dr. Roberta Gasparro, born in 1988, is a distinguished professional in the field of Dentistry and Oral Surgery. She is a resident of Laureana Cilento, Salerno, Italy. Dr. Gasparro has established herself as a highly qualified dentist and researcher, recognized for her significant contributions to clinical and experimental medicine.

Professional Profile 

Education🎓

Dr. Gasparro began her academic journey with a Scientific High School Diploma in 2007, achieving top marks. She then pursued Biotechnology Sciences at the University of Naples Federico II, later transitioning to Dentistry and Dental Prosthetics. She graduated in 2013 with the highest honors, receiving special mention and publication dignity. In 2017, she earned a PhD in “Clinical and Experimental Medicine” from the same university. Her education was further enhanced by an Advanced Training Course in Oral and Reconstructive Surgery in 2023.

 💼Work Experience

Dr. Gasparro has held various prestigious positions throughout her career. After obtaining her degree, she worked as a Research Fellow at the University of Naples Federico II in the Department of Neurosciences, Reproductive, and Odontostomatological Sciences. In 2019, she was ranked first in the competition for the Specialization in Oral Surgery. Currently, she serves as a Contract Professor at the University of Salerno, where she teaches Odontostomatological Clinic modules in the Integrated Therapy courses.

 🛠️Skills

Dr. Gasparro’s skills include expertise in Oral Surgery, Implantology, and Maxillofacial Pathology and Therapy. Her academic background and practical experience have equipped her with advanced knowledge in clinical and experimental dentistry, as well as a deep understanding of complex surgical procedures.

 🏆Awards and Honors

Dr. Gasparro’s excellence has been recognized with several awards, particularly for her oral presentations and poster contributions at national and international conferences. Her work has earned her multiple honors, including being a recipient of special mention for her degree and PhD achievements.

 Membership 🏛️and Affiliations 🤝

As an active member of various national and international scientific societies, Dr. Gasparro holds several responsibilities, contributing to the advancement of dental and medical sciences. Her involvement in these organizations reflects her commitment to staying at the forefront of her field.

 Teaching Experience👨‍🏫

Dr. Gasparro has extensive teaching experience, having served as a Contract Professor at the University of Salerno since 2020. She has taught the Odontostomatological Clinic module in both Integrated Therapy I and II courses for the Master’s Degree in Dentistry and Dental Prosthetics. Her teaching has been highly regarded, and she continues to contribute to the education of future dental professionals.

 Research Focus 🔬

Dr. Gasparro’s research is focused on clinical and experimental medicine, with a particular emphasis on Oral Surgery, Implantology, and Maxillofacial Pathology. She has authored 53 publications in indexed and impact-factor journals, with an H index of 13 and a total of 536 citations, underscoring the impact of her research. Her work has been published in high-ranking journals, including 13 Q1 articles, one of which is in the top decile.

📖Publications : 

  • The role of cognitive and non‐cognitive factors in dental anxiety: A mediation model
    🗓️ 2021
    📘 European Journal of Oral Sciences
    ✍️ Authors: C. Scandurra, R. Gasparro, P. Dolce, V. Bochicchio, B. Muzii, G. Sammartino, …

 

  • Treatment of periodontal pockets at the distal aspect of mandibular second molar after surgical removal of impacted third molar and application of L-PRF: A split-mouth study
    🗓️ 2020
    📘 Quintessence International
    ✍️ Authors: R. Gasparro, G. Sammartino, M. Mariniello, A. Espedito di Lauro, …

 

  • Rhein: A novel antibacterial compound against Streptococcus mutans infection
    🗓️ 2022
    📘 Microbiological Research
    ✍️ Authors: V. Folliero, F. Dell’Annunziata, E. Roscetto, A. Amato, R. Gasparro, …

 

  • Multidisciplinary approach to fused maxillary central incisors: A case report
    🗓️ 2014
    📘 Journal of Medical Case Reports
    ✍️ Authors: G. Sammartino, V. Cerone, R. Gasparro, F. Riccitiello, O. Trosino

 

  • Use of injectable platelet‐rich fibrin in the treatment of plasma cell mucositis of the oral cavity refractory to corticosteroid therapy: A case report
    🗓️ 2019
    📘 Dermatologic Therapy
    ✍️ Authors: R. Gasparro, D. Adamo, M. Masucci, G. Sammartino, M.D. Mignogna

 

  • Three-dimensional cell cultures: The bridge between in vitro and in vivo models
    🗓️ 2023
    📘 International Journal of Molecular Sciences
    ✍️ Authors: O. Urzì, R. Gasparro, E. Costanzo, A. De Luca, G. Giavaresi, S. Fontana, …

 

  • Burning fog: Cognitive impairment in burning mouth syndrome
    🗓️ 2021
    📘 Frontiers in Aging Neuroscience
    ✍️ Authors: F. Canfora, E. Calabria, R. Cuocolo, L. Ugga, G. Buono, G. Marenzi, …

 

  • Peri-implant soft tissue management: Cairo opinion consensus conference
    🗓️ 2020
    📘 International Journal of Environmental Research and Public Health
    ✍️ Authors: F.S.L. Del Amo, S.H. Yu, G. Sammartino, A. Sculean, G. Zucchelli, G. Rasperini, …

 

  • Effectiveness of surgical procedures in the acceleration of orthodontic tooth movement: Findings from systematic reviews and meta‐analyses
    🗓️ 2022
    📘 Japanese Dental Science Review
    ✍️ Authors: R. Gasparro, R. Bucci, F. De Rosa, G. Sammartino, P. Bucci, V. D’Antò, …

 

  • The use of piezosurgery in genioplasty
    🗓️ 2016
    📘 Journal of Craniofacial Surgery
    ✍️ Authors: R. Rullo, V.M. Festa, F. Rullo, O. Trosino, V. Cerone, R. Gasparro, L. Laino, …

 

  • Platelet‐rich plasma counteracts detrimental effect of high‐glucose concentrations on mesenchymal stem cells from Bichat fat pad
    🗓️ 2020
    📘 Journal of Tissue Engineering and Regenerative Medicine
    ✍️ Authors: V. D’Esposito, M. Lecce, G. Marenzi, S. Cabaro, M.R. Ambrosio, …

 

  • Clinical relevance of bone density values from CT related to dental implant stability: A retrospective study
    🗓️ 2018
    📘 BioMed Research International
    ✍️ Authors: V. Bruno, C. Berti, C. Barausse, M. Badino, R. Gasparro, D.R. Ippolito, …

 

  • Four-year post-loading results of full-arch rehabilitation with immediate placement and immediate loading implants: A retrospective controlled study
    🗓️ 2017
    📘 Quintessence International
    ✍️ Authors: A. Simonpieri, R. Gasparro, G. Pantaleo, J. Mignogna, F. Riccitiello, …

 

Mark Myers | Neuroscience | Excellence in Research

Posted on by sciencefather

Dr Mark Myers | Neuroscience | Excellence in Research

Professor  at University of Tennessee Health Science Center, United States

Mark H. Myers, Ph.D. is a distinguished professional in the fields of computer science, biomedical engineering, and computational neurodynamics. He is currently an Assistant Professor in the Department of Anatomy and Neurobiology at the University of Tennessee Health Science Center (UTHSC), a position he has held since 2014, and serves as an Adjunct Professor in the Mathematics/Computer Science Department at Christian Brothers University since 2020.

Profile:

scopus

Education:

🎓 Ph.D. in Computer Science – University of Memphis (2005-2011) 🧠 Dissertation: Simulation of Abnormal/Normal Brain States Using the KIV Model 🎓 M.Sc. in Biomedical Engineering – University of Memphis 🧩 Thesis: Vagus Nerve Implant Simulator for Seizure Prediction and Treatment 🎓 M.Sc. in Computer Science – University of Memphis (2004-2005) 🧪 Thesis: Optimization of EEG Analysis for Cognitive Phase Transitions 🎓 B.Sc. in Physics, Minor in Math – University of Alabama

Professional Experience:

🔬 Assistant Professor – University of Tennessee Health Science Center, College of Medicine (2014-present) 🖥️ Adjunct Professor – Christian Brothers University, Mathematics/Computer Science Department (2020-present) 📊 Sr. Data Science Architect Consultant – Cognosante, LLC for Veteran’s Administration (2020-2021) 💼 CTO/CEO – NeuroDyne, Inc (2017-present) 🔬 Director, Center for Biomedical Informatics – UTHSC, College of Medicine (2015-2016) 🔬 Assistant Professor, Ophthalmology – UTHSC, College of Medicine (2012-2015) 👨‍🏫 Adjunct Professor, Computer Science – University of Memphis (2012-2015) 🔬 Research Assistant – Computational Neurodynamics Lab, University of Memphis (2004-2012) ⚓ Sr. R&D Software Engineer Consultant – U.S. Navy-Department of Defense Contractor (2009-2011) 📦 Senior Enterprise Architect – FedEx Express (2006-2009)

Associations: 🧠 Guest Editor and Topic Editor – Frontiers in Neuroscience, Brain Sciences 🧠 Review Editor – Frontiers in Computational Neuroscience 🧬 Member – Society for Neuroscience, International Neural Network Society, The Association of Research in Vision and Ophthalmology

Teaching Experience:

👨‍🏫 Adjunct Professor – Christian Brothers University Courses: Neural Networks, Operating Systems, C Programming, Introduction to AI 👨‍🏫 Assistant Professor – UTHSC Courses: Neuroanatomy Lab 👨‍🏫 Adjunct Professor – University of Memphis Courses: Java Network Programming, Control Theory/Systems Neuroscience 👨‍🏫 Adjunct Professor – Rhodes College Courses: Physics I, Physics II

Research  Focus   :

Dr. Mark H. Myers’ neuroscience research is centered around several key areas:

Seizure Prediction and Detection:Development of Algorithms: Dr. Myers has developed advanced algorithms for the prediction and detection of seizures, with a focus on non-invasive techniques using EEG data.Ambulatory Monitoring: His patented work on ambulatory seizure monitoring systems aims to provide real-time detection and management of seizures, improving patient outcomes.

Brain-State Simulation:KIV Model: His Ph.D. dissertation involved the simulation of abnormal and normal brain states using the KIV model, contributing to the understanding of various neurological conditions.

EEG Analysis and Cognitive Phase Transitions:EEG Optimization: Dr. Myers’ research includes optimizing EEG analysis to detect cognitive phase transitions, enhancing the ability to monitor and interpret brain activity during different cognitive states.

Neurodynamic Modeling:Mesoscopic Modeling: He has worked on modeling neuron population dynamics to study brain disorders such as epilepsy, providing insights into the neural mechanisms underlying these conditions.

Neural Interfaces and Vagus Nerve Stimulation:Vagus Nerve Research: His master’s thesis on a vagus nerve implant simulator aimed at predicting and treating seizures showcases his interest in neural interfaces and their therapeutic potential.

Traumatic Brain Injury (TBI):Visual Evoked Potentials: Recent research by Dr. Myers investigates the effects of mild traumatic brain injuries on visual pathways, providing valuable data on the impact of TBI on cognitive functions.

Multisensory Integration:Audiovisual Processing: His studies on multisensory integration, particularly in patients with inherited retinal dystrophies, explore how the brain processes and integrates information from different sensory modalities.

Collaborative Research:NSF and DOD Grants: Dr. Myers has led and contributed to numerous research projects funded by the National Science Foundation and the Department of Defense, focusing on brain-computer interfaces, cognitive modeling, and autonomous systems.

Citations:

📚Citations: 179

📄 Documents: 173

📊h-index: 8

Publication Top Notes:

  1. Auditory and olfactory findings in patients with USH2A-related retinal degeneration—Findings at baseline from the rate of progression in USH2A-related retinal degeneration natural history study (RUSH2A)
    Authors: Iannaccone, A., Brewer, C.C., Cheng, P., … Stingl, K., Zein, W.M.
    Journal: American Journal of Medical Genetics, Part A, 2021, 185(12), pp. 3717–3727
  2. Automatic detection of a student’s affective states for intelligent teaching systems
    Author: Myers, M.H.
    Journal: Brain Sciences, 2021, 11(3), pp. 1–15, 331
  3. Seizure localization using EEG analytical signals
    Authors: Myers, M.H., Padmanabha, A., Bidelman, G.M., Wheless, J.W.
    Journal: Clinical Neurophysiology, 2020, 131(9), pp. 2131–2139
  4. Frontal cortex selectively overrides auditory processing to bias perception for looming sonic motion
    Authors: Bidelman, G.M., Myers, M.H.
    Journal: Brain Research, 2020, 1726, 146507
  5. Mesoscopic neuron population modeling of normal/epileptic brain dynamics
    Authors: Myers, M.H., Kozma, R.
    Journal: Cognitive Neurodynamics, 2018, 12(2), pp. 211–223
  6. A pilot investigation of audiovisual processing and multisensory integration in patients with inherited retinal dystrophies
    Authors: Myers, M.H., Iannaccone, A., Bidelman, G.M.
    Journal: BMC Ophthalmology, 2017, 17(1), pp. 240